Cell Signaling Technology

Product Pathways - Chromatin Regulation / Epigenetics

DNMT3A Antibody #2160

DNA (cytosine-5)-methyltransferase 3A   DNA methylation   DNA methyltransferase HsaIIIA   DNA MTase HsaIIIAM. HsaIIIA   DNMT   methyl-DNA   methylated DNA  

No. Size Price
2160S 100 µl ( 10 western blots ) ¥3,100.00 现货查询 购买询价
2160 carrier free & custom formulation / quantityemail request
Applications Dilution Species-Reactivity Sensitivity MW (kDa) Isotype
W 1:1000 Human,Mouse,Rat,Monkey, Endogenous 130 Rabbit
IP 1:25

Species cross-reactivity is determined by western blot.

Applications Key: W=Western Blotting, IP=Immunoprecipitation,


Species predicted to react based on 100% sequence homology: Bovine,

Specificity / Sensitivity

DNMT3A Antibody detects endogenous levels of total DNMT3A protein. The antibody does not cross-react with DNMT3B or other DNMT proteins.

DNMT3A Antibody能够检测内源性DNMT3A总蛋白水平。该抗体不能与DNMT3B或其它DNMT蛋白发生相互作用。

Source / Purification

Polyclonal antibodies are produced by immunizing animals with a synthetic peptide corresponding to the human DNMT3A protein. Antibodies are purified by protein A and peptide affinity chromatography.


Western Blotting

Western Blotting

Western blot analysis of cell extracts from 293, NIH/3T3 and H-4-II-E cells using DNMT3A Antibody.

使用DNMT3A Antibody,免疫印迹(Western blot)分析293、NIH/3T3和H-4-II-E细胞系中DNMT3A蛋白水平。


Methylation of DNA at cytosine residues in mammalian cells is a heritable, epigenetic modification that is critical for proper regulation of gene expression, genomic imprinting and development (1,2). Three families of mammalian DNA methyltransferases have been identified: DNMT1, DNMT2 and DNMT3 (1,2). DNMT1 is constitutively expressed in proliferating cells and functions as a maintenance methyltransferase, transferring proper methylation patterns to newly synthesized DNA during replication. DNMT3A and DNMT3B are strongly expressed in embryonic stem cells with reduced expression in adult somatic tissues. DNMT3A and DNMT3B function as de novo methyltransferases that methylate previously unmethylated regions of DNA. DNMT2 is expressed at low levels in adult somatic tissues and its inactivation affects neither de novo nor maintenance DNA methylation. DNMT1, DNMT3A and DNMT3B together form a protein complex that interacts with histone deacetylases (HDAC1, HDAC2, Sin3A), transcriptional repressor proteins (RB, TAZ-1) and heterochromatin proteins (HP1, SUV39H1), to maintain proper levels of DNA methylation and facilitate gene silencing (3-8). Improper DNA methylation contributes to diseased states such as cancer (1,2). Hypermethylation of promoter CpG islands within tumor suppressor genes correlates with gene silencing and the development of cancer. In addition, hypomethylation of bulk genomic DNA correlates with and may contribute to the onset of cancer. DNMT1, DNMT3A and DNMT3B are over-expressed in many cancers, including acute and chronic myelogenous leukemias, in addition to colon, breast and stomach carcinomas (9-12).

在哺乳动物细胞中DNA在胞嘧啶残基的甲基化是一个可遗传的表观遗传修饰,它对于基因表达、基因组印迹和发育起着关键作用(1,2)。哺乳细胞中DNA甲基转移酶的三个家族已经被鉴定:DNMT1、DNMT2和DNMT3 (1,2)。DNMT1蛋白在增殖的细胞中结构性表达,并且作为维持甲基转移酶的功能,在复制期间可传递合适的甲基到新合成的DNA上。DNMT3A和DNMT3B在胚胎干细胞中高表达,而在成年体细胞组织中表达减少。DNMT3A和DNMT3B蛋白具有在甲基转移酶的初始阶段的功能,该酶能使DNA的未甲基化区域发生甲基化。在成年体细胞组织中DNMT2蛋白在低水平表达,并且它的非活性状态既不影响初始阶段也不影响维持DNA甲基化。DNMT1、DNMT3A和DNMT3B蛋白一起形成一个蛋白复合物,该复合物能与组蛋白去乙酰酶(HDAC1, HDAC2, Sin3A)、转录抑制蛋白(RB, TAZ-1)和异染色质蛋白(HP1, SUV39H1)发生相互作用,从而维持DNA甲基化的合适水平和有助于基因沉默(3-8)。不正确的DNA甲基化导致疾病例如癌症(1,2)。肿瘤抑制基因的启动子CpG岛的高度甲基化与基因沉默和癌症的发展有关。因此,大多数基因组DNA的低甲基化与癌症初始阶段有关并且可能有助于形成。除了结肠、乳腺和胃癌之外,DNMT1、DNMT3A和DNMT3B蛋白在许多癌症中高表达,包括急性和慢性粒细胞性白血病(9-12)。

  1. Hermann, A. et al. (2004) Cell. Mol. Life Sci. 61, 2571-2587.
  2. Turek-Plewa, J. and Jagodziński, P.P. (2005) Cell. Mol. Biol. Lett. 10, 631-647.
  3. Kim, G.D. et al. (2002) EMBO J. 21, 4183-4195.
  4. Fuks, F. et al. (2001) EMBO J. 20, 2536-2544.
  5. Geiman, T.M. et al. (2004) Biochem. Biophys. Res. Commun. 318, 544-555.
  6. Rountree, M.R. et al. (2000) Nat. Genet. 25, 269-277.
  7. Pradhan, S. and Kim, G.D. (2002) EMBO J. 21, 779-788.
  8. Fuks, F. et al. (2003) Nucleic Acids Res. 31, 2305-2312.
  9. Mizuno, S. et al. (2001) Blood 97, 1172-1179.
  10. Robertson, K.D. et al. (1999) Nucleic Acids Res. 27, 2291-2298.
  11. Xie, S. et al. (1999) Gene 236, 87-95.
  12. Kanai, Y. et al. (2001) Int. J. Cancer 91, 205-212.

Application References

Have you published research involving the use of our products? If so we'd love to hear about it. Please let us know!


Companion Products

For Research Use Only. Not For Use In Diagnostic Procedures.

Cell Signaling Technology is a trademark of Cell Signaling Technology, Inc.

Cell Signaling Technology® is a trademark of Cell Signaling Technology, Inc.

用户评论 --- 共 0


我要参与评论 :